Aurinia Pharmaceuticals Inc. is a biopharmaceutical company developing and marketing therapies for autoimmune diseases, particularly nephrology and organ rejection related conditions.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!